GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biotika AS (XBRA:1BSL01AE) » Definitions » PB Ratio

Biotika AS (XBRA:1BSL01AE) PB Ratio : 0.61 (As of May. 26, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Biotika AS PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-26), Biotika AS's share price is €23.00. Biotika AS's Book Value per Share for the quarter that ended in Jun. 2023 was €37.68. Hence, Biotika AS's PB Ratio of today is 0.61.

Good Sign:

Biotika AS stock PB Ratio (=0.61) is close to 1-year low of 0.55

The historical rank and industry rank for Biotika AS's PB Ratio or its related term are showing as below:

XBRA:1BSL01AE' s PB Ratio Range Over the Past 10 Years
Min: 0.42   Med: 0.79   Max: 1.39
Current: 0.61

During the past 13 years, Biotika AS's highest PB Ratio was 1.39. The lowest was 0.42. And the median was 0.79.

XBRA:1BSL01AE's PB Ratio is ranked better than
91.62% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2 vs XBRA:1BSL01AE: 0.61

During the past 12 months, Biotika AS's average Book Value Per Share Growth Rate was 2.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -3.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -2.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -0.60% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Biotika AS was 14.50% per year. The lowest was -3.50% per year. And the median was -0.50% per year.

Back to Basics: PB Ratio


Biotika AS PB Ratio Historical Data

The historical data trend for Biotika AS's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotika AS PB Ratio Chart

Biotika AS Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.77 0.77 1.05 0.63

Biotika AS Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 1.05 1.05 0.63 0.58

Competitive Comparison of Biotika AS's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biotika AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotika AS's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biotika AS's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biotika AS's PB Ratio falls into.



Biotika AS PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biotika AS's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=23.00/37.679
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Biotika AS  (XBRA:1BSL01AE) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Biotika AS PB Ratio Related Terms

Thank you for viewing the detailed overview of Biotika AS's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotika AS (XBRA:1BSL01AE) Business Description

Traded in Other Exchanges
N/A
Address
Slovenskc Lupca 566, Banská Bystrica, SVK, 976 13
Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.

Biotika AS (XBRA:1BSL01AE) Headlines

No Headlines